Integrating network pharmacology and experimental validation to uncover the mechanisms of Ganoderma lucidum in ameliorating neuroinflammation in Alzheimer's disease.
The Journal of pharmacy and pharmacology · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
AnimalsReishiAlzheimer DiseaseMiceJanus Kinase 2Amyloid beta-PeptidesSTAT1 Transcription FactorNeuroprotective AgentsMolecular Docking SimulationNetwork PharmacologyNeuroinflammatory DiseasesMaleAnti-Inflammatory AgentsHippocampusDisease Models, AnimalMicrogliaMacrophagesPeptide FragmentsMolecular Dynamics SimulationSignal TransductionGanoderma lucidumAlzheimer’s diseaseAβ1–42network pharmacologyneuroinflammation
Come citare questo studio
Feiya Sheng, Jia-Mei Yu, Qiao Yang, Rigu Jipei, Wen-Qi Xie, Gu Zhan, Yan Zhang, Le-Le Zhang. (2026). Integrating network pharmacology and experimental validation to uncover the mechanisms of Ganoderma lucidum in ameliorating neuroinflammation in Alzheimer's disease.. The Journal of pharmacy and pharmacology. DOI: 10.1093/jpp/rgag105
Consulta la pubblicazione originale ↗